Cass Information [CASS] vs Acuren [TIC] Detailed Stock Comparison
Cass Information
NASDAQ
Loading...
Acuren
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cass Information wins in 11 metrics, Acuren wins in 5 metrics, with 0 ties. Cass Information appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cass Information | Acuren | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.10 | 44.48 | Cass Information |
| Price-to-Book Ratio | 2.27 | 1.02 | Acuren |
| Debt-to-Equity Ratio | 2.02 | 71.71 | Cass Information |
| PEG Ratio | 16.30 | -0.08 | Acuren |
| EV/EBITDA | 6.64 | 24.97 | Cass Information |
| Profit Margin (TTM) | 11.53% | -13.14% | Cass Information |
| Operating Margin (TTM) | 21.49% | -3.75% | Cass Information |
| EBITDA Margin (TTM) | 21.49% | N/A | N/A |
| Return on Equity | 9.14% | -19.28% | Cass Information |
| Return on Assets (TTM) | 1.17% | -1.04% | Cass Information |
| Free Cash Flow (TTM) | $29.62M | $73.67M | Acuren |
| Dividend Yield | 3.58% | N/A | N/A |
| 1-Year Return | 2.49% | -25.63% | Cass Information |
| Price-to-Sales Ratio (TTM) | 2.48 | 1.68 | Acuren |
| Enterprise Value | $331.73M | $1.84B | Acuren |
| EV/Revenue Ratio | 1.51 | 1.66 | Cass Information |
| Gross Profit Margin (TTM) | N/A | 18.64% | N/A |
| Revenue per Share (TTM) | $16 | $13 | Cass Information |
| Earnings per Share (Diluted) | $1.58 | $-1.25 | Cass Information |
| Beta (Stock Volatility) | 0.49 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cass Information vs Acuren Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cass Information | -0.10% | 4.06% | -9.08% | -3.35% | -4.85% | 2.82% |
| Acuren | -3.50% | -15.05% | -17.44% | -9.56% | -21.92% | -21.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cass Information | 2.49% | 9.91% | 4.48% | -19.69% | 51.62% | 162.84% |
| Acuren | -25.63% | -25.63% | 240.73% | -99.93% | -99.88% | -99.88% |
Performance & Financial Health Analysis: Cass Information vs Acuren
| Metric | CASS | TIC |
|---|---|---|
| Market Information | ||
| Market Cap | $545.56M | $1.86B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 67,060 | 4,317,010 |
| 90 Day Avg. Volume | 74,047 | 2,700,947 |
| Last Close | $41.24 | $9.37 |
| 52 Week Range | $38.01 - $47.14 | $8.76 - $14.28 |
| % from 52W High | -12.52% | -34.38% |
| All-Time High | $68.81 (Dec 30, 2013) | $14,700.00 (Jul 03, 2017) |
| % from All-Time High | -40.07% | -99.94% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.05% |
| Quarterly Earnings Growth | 0.98% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | -0.13% |
| Operating Margin (TTM) | 0.21% | -0.04% |
| Return on Equity (TTM) | 0.09% | -0.19% |
| Debt to Equity (MRQ) | 2.02 | 71.71 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $18.13 | $9.22 |
| Cash per Share (MRQ) | $16.51 | $1.27 |
| Operating Cash Flow (TTM) | $38.71M | $34.94M |
| Levered Free Cash Flow (TTM) | $58.63M | $172.22M |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.58% | N/A |
| Last 12-Month Dividend | $1.54 | N/A |
Valuation & Enterprise Metrics Analysis: Cass Information vs Acuren
| Metric | CASS | TIC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.10 | 44.48 |
| Forward P/E | 16.30 | 30.14 |
| PEG Ratio | 16.30 | -0.08 |
| Price to Sales (TTM) | 2.48 | 1.68 |
| Price to Book (MRQ) | 2.27 | 1.02 |
| Market Capitalization | ||
| Market Capitalization | $545.56M | $1.86B |
| Enterprise Value | $331.73M | $1.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.51 | 1.66 |
| Enterprise to EBITDA | 6.64 | 24.97 |
| Risk & Other Metrics | ||
| Beta | 0.49 | N/A |
| Book Value per Share (MRQ) | $18.13 | $9.22 |
Financial Statements Comparison: Cass Information vs Acuren
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CASS | TIC |
|---|---|---|
| Revenue/Sales | $47.31M | $234.22M |
| Cost of Goods Sold | N/A | $190.55M |
| Gross Profit | N/A | $43.67M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $-8.79M |
| EBITDA | N/A | $20.93M |
| Pre-Tax Income | $10.88M | $-24.33M |
| Income Tax | $2.33M | $1.47M |
| Net Income (Profit) | $8.97M | $-25.79M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CASS | TIC |
|---|---|---|
| Cash & Equivalents | $220.67M | $155.74M |
| Total Current Assets | N/A | $376.67M |
| Total Current Liabilities | N/A | $107.93M |
| Long-Term Debt | N/A | $784.25M |
| Total Shareholders Equity | $234.25M | $1.13B |
| Retained Earnings | $153.28M | $-132.78M |
| Property, Plant & Equipment | N/A | $30.52M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CASS | TIC |
|---|---|---|
| Operating Cash Flow | $17.09M | $35.09M |
| Capital Expenditures | $-2.57M | $-4.18M |
| Free Cash Flow | $18.99M | $28.32M |
| Debt Repayment | N/A | $-4.44M |
| Common Stock Repurchase | $-5.08M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CASS | TIC |
|---|---|---|
| Shares Short | 194,964 | 8.45M |
| Short Ratio | 3.03 | 3.54 |
| Short % of Float | 0.02% | 0.16% |
| Average Daily Volume (10 Day) | 67,060 | 4,317,010 |
| Average Daily Volume (90 Day) | 74,047 | 2,700,947 |
| Shares Outstanding | 13.50M | 121.48M |
| Float Shares | 11.69M | 44.17M |
| % Held by Insiders | 0.11% | 0.10% |
| % Held by Institutions | 0.71% | 0.51% |
Dividend Analysis & Yield Comparison: Cass Information vs Acuren
| Metric | CASS | TIC |
|---|---|---|
| Last 12-Month Dividend | $1.54 | N/A |
| Last 12-Month Dividend Yield | 3.58% | N/A |
| 3-Year Avg Annual Dividend | $1.29 | N/A |
| 3-Year Avg Dividend Yield | 0.71% | N/A |
| 3-Year Total Dividends | $3.88 | N/A |
| Ex-Dividend Date | Sep 05, 2025 | N/A |